Using two GEO datasets (GSE64472 and GSE86525), significantly increased the expression of AKAP12 was validated in vandetanib-resistant NSCLC (Figure 1F) and BV-resistant colon cancer (Figure 1G). This evidence concerns the gene AKAP12 and malignant colon neoplasm.